Shanghai Zhongshan Hospital: Hemorrhage trials

The registry lists 10 Hemorrhage studies with Shanghai Zhongshan Hospital as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 4 2No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Improve the Strategies of Endoscopic and Interventional Treatment of Gastroesophageal Hemorrhage in Portal HypertensionRecruitingNCT06970509
• Management of Oxaliplatin-related Gastroesophageal Variceal BleedingStatus unknownNCT05141617Not applicable
• Oxaliplatin-induced Portal HypertensionStatus unknownNCT04524676Not applicable
• Multi-center Application of Bivalirudin in Left Atrial Appendage OcclusionStatus unknownNCT04195997Phase 4
• Blood Pressure During ESD is Related With the Postoperative BleedingStatus unknownNCT03070665Not applicable
• Rifaximin in Patients With Gastroesophageal Variceal BleedingCompletedNCT02991612Not applicable
• Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal BleedingStatus unknownNCT02964195Not applicable
• The Effect of Carvedilol Vs Propranolol in Cirrhotic Patients With Variceal BleedingStatus unknownNCT02385422Phase 4
• Effects of Terlipressin When Usual Somatostatin or Octreotide Dose FailsStatus unknownNCT02311608
• The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic SurgeryCompletedNCT01267305Not applicable